AAOS Now, June 2018
-
Residents Transitioning to Practice Need to Fully Understand the Medical Liability System
Clinicians practice within a litigious environment, the nature of which varies depending on practice location and subspecialty. Residents who are transitioning from training into practice, therefore, need to be familiar with the medical liability system and how variation in tort protection laws among states may inform their choice of future practice location.
-
Tips for Utilizing ICD-10-CM
In May 2015, most orthopaedic surgeons and their staff were highly focused on learning the new diagnostic language of ICD-10-CM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, Clinical Modification). That’s because the new diagnosis codes were scheduled to replace ICD-9-CM in October 2015. Three years later, practices are still learning how to utilize the ICD-10-CM code set to support the services they perform.
-
Should I Sell My Practice to Private Equity?
As we all know, times change and healthcare trends re-emerge. In recent years, private equity has successfully consolidated and strengthened several specialties, including dermatology, dentistry, and ophthalmology. The focus has now turned to orthopaedics/musculoskeletal care.
-
Have You Heard the Latest Professional Liability Risk?
The list of liability risks for physicians continues to increase. On behalf of the Medical Liability Committee, this article presents new risks via highlights from a recent discussion with Jeannine M. Foran, BSN, JD, a Connecticut healthcare attorney who leads the Health Care Practice Advisory Group at Heidell, Pittoni, Murphy & Bach, LLP, in Bridgeport, Conn. Dr. Marks: What is the latest liability risk that physicians should be concerned about? Ms.
-
The Crisis in Orthopaedic Technology Puts Evidence-based Medicine at Risk
Improvements in orthopaedic patient care are typically connected to improvements in orthopaedic technology. However, the supply of new implants and procedures is not guaranteed. The successful commercialization of truly novel orthopaedic technology currently faces stiff headwinds, including regulatory risk, payer risk, and market risk. This may reduce interest in financing novel technologies within the venture community and among major device manufacturers.
-
Clinical Trials for Cervical Disk Replacement
Each of the seven cervical total disk replacements (cTDR) currently available in the United States has undergone a clinical trial providing evidence of safety and efficacy that supports U.S. Food and Drug Administration (FDA) premarket approval.